Quanta to Exhibit at the 56th Annual ERA-EDTA Congress
11 June 2019: Quanta Dialysis Technologies Ltd, a pioneering British medical device company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that the Company will be exhibiting at the 56th Annual European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday 13th to Sunday 16th June, at the HUNGEXPO in Budapest, Hungary, at booth number 1.040.
Ahead of commercial launch, planned for Q4 2019, Quanta will be showcasing its updated, state-of-the-art personal haemodialysis system, SC+, designed to offer patients flexibility enabling them to fit treatment around everyday life. SC+ maintains its small, compact form factor whilst offering patients the latest technology, including a high-resolution touch screen interface designed for simplicity, as well as capabilities enabling integration with digital health solutions.
If you would like to arrange a meeting with John E. Milad, Chief Executive Officer or Dr. Paul Komenda, Chief Medical Officer, please contact enquiries@quantadt.com. ERA-EDTA brings together worldwide physicians and kidney specialists to learn and share the latest advances in the field of clinical nephrology, dialysis, renal transplantation, and related subjects.